FDA
-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) awarded U.S. patent for proprietary formulation of oral liquid hydrocortisone
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) Announces Commercial Availability of Betaine Anhydrous for Oral Solution
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) submitted NDA response for its dehydrated alcohol injection product candidate to FDA
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) Announces Sale of Hospital Products to Dr. Reddy’s (RDY) for Up to $50M
-
251,877 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All